Dermatology Dialogies: Aryl Hydrocarbon Receptor Agonism
1-6 of 6
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismManaging Patient Expectations with Topical Therapies
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismPotential Impact of Aryl Hydrocarbon Activation on Pigment
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismVarious Benefits of Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismMechanism of Action for Aryl Hydrocarbon Receptor Agonists
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismTapinarof’s Place in Inflammatory Disease Treatment
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD
Dermatology Dialogies: Aryl Hydrocarbon Receptor AgonismSkin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Neal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAADNeal Bhatia, MD, FAAD; Joshua Grosshandler, MD, FAAD